Hot Pursuit     05-Sep-23
Biocon Ltd spurts 1.53%
Biocon Ltd is quoting at Rs 265.35, up 1.53% on the day as on 12:49 IST on the NSE. The stock is down 9.25% in last one year as compared to a 10.67% jump in NIFTY and a 19.73% jump in the Nifty Metal index.

Biocon Ltd is up for a third straight session in a row. The stock is quoting at Rs 265.35, up 1.53% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.05% on the day, quoting at 19539.3. The Sensex is at 65663.62, up 0.05%. Biocon Ltd has gained around 1.51% in last one month.

Meanwhile, Nifty Metal index of which Biocon Ltd is a constituent, has gained around 2.56% in last one month and is currently quoting at 15052.6, up 0.21% on the day. The volume in the stock stood at 28.65 lakh shares today, compared to the daily average of 46.63 lakh shares in last one month.

The benchmark September futures contract for the stock is quoting at Rs 267.2, up 1.56% on the day. Biocon Ltd is down 9.25% in last one year as compared to a 10.67% jump in NIFTY and a 19.73% jump in the Nifty Metal index.

The PE of the stock is 293.37 based on TTM earnings ending June 23.

Previous News
  Biocon consolidated net profit declines 56.74% in the March 2024 quarter
 ( Results - Announcements 16-May-24   18:25 )
  Biocon Ltd rises for third consecutive session
 ( Hot Pursuit - 20-Aug-24   13:05 )
  Biocon Biologics receives UDFDA approval for Yesafili™
 ( Corporate News - 21-May-24   09:13 )
  Biocon's new monoclonal antibodies facility in India get manufacturing approval from EMA
 ( Hot Pursuit - 24-Jun-24   09:34 )
  Biocon Ltd spurts 3.48%, gains for five straight sessions
 ( Hot Pursuit - 26-Jul-24   13:00 )
  Biocon PAT slides 57% to Rs 136 crore in Q4 FY24
 ( Hot Pursuit - 17-May-24   10:37 )
  Biocon Ltd up for third straight session
 ( Hot Pursuit - 23-May-24   13:05 )
  Biocon Biologics receives GMP certifications for its Indian and Malaysian manufacturing units
 ( Corporate News - 24-Jun-24   09:01 )
  Biocon Ltd spurts 0.71%, rises for fifth straight session
 ( Hot Pursuit - 19-Jun-23   13:00 )
  Biocon jumps after receiving SAHPRA approval for Tacrolimus capsules
 ( Hot Pursuit - 22-Apr-24   11:39 )
  Biocon Biologics divests its non-crore branded formulations biz in India
 ( Corporate News - 10-Nov-23   12:06 )
Other Stories
  Avantel Q2 PAT jumps 42% YoY to Rs 23 cr
  05-Oct-24   17:03
  Equitas SFB total deposits jump 29% YoY in Q2 FY25
  05-Oct-24   16:28
  Ujjivan SFB total deposits rises 17% in Q2 FY25
  05-Oct-24   15:34
  L&T Finance retail disbursements jump 12% YoY in Q2 FY25
  05-Oct-24   14:31
  Bandhan Bank records over 21% YoY jump in loan book during Q2 FY25; deposits at Rs 1.42 lakh crore
  05-Oct-24   13:32
  Lupin's Pune-based biotech facility gets 5 observations from US FDA
  05-Oct-24   13:20
  Macrotech Developers pre-sales jumps 21% YoY in Q2 FY25
  05-Oct-24   09:04
  UCO Bank’s total advances jump 19% YoY in Q2 FY25
  04-Oct-24   15:15
  Vakrangee Ltd leads losers in 'A' group
  04-Oct-24   15:00
  Kamdhenu Ventures Ltd leads losers in 'B' group
  04-Oct-24   14:45
Back Top